Turning healthcare innovation into adoption at scale.

Turning healthcare innovation into adoption at scale.

Turning healthcare innovation into adoption at scale.

We help health and life sciences companies navigate the complex journey from breakthrough innovation to adoption at scale: combining health-system strategy, policy and influence, positioning, communications and market development to build trust, reputation and growth.

$130mSeries C raised
$12m+Via lead-generation activity
Multi-millionGlobal pharma contracts
167%Increase in brand impressions
$130mSeries C raised
$12m+Via lead-generation activity
Multi-millionGlobal pharma contracts
167%Increase in brand impressions

What we do

From innovation to impact.

Navigate the NHS and health ecosystem

We help companies understand how health systems really work — the decision-makers, clinical pathways, policy environment and partnerships that determine whether innovation gets adopted.

Shape strategy and the proposition

We turn complex science and technology into a clear, compelling proposition — defining the problem it solves, where it creates value and why it matters to health systems.

Shape policy and influence

We anticipate political, policy and regulatory change, build influential relationships and help create the conditions in which innovation can succeed.

Accelerate adoption and growth

We help turn evidence and opportunity into adoption — developing routes to market, building strategic partnerships and supporting commercial growth at scale.

Build the brand, narrative and reputation

We build and refresh brands that bring complex innovation to life — creating the positioning, narrative and communications that build understanding, trust and reputation.

The gap between invention and adoption is where many brilliant companies get stuck.

The gap between invention and adoption is where many brilliant companies get stuck.

The science may be strong, the technology may work, the investment may be there – but adoption requires something different: understanding the system around the innovation.

The science may be strong, the technology may work, the investment may be there – but adoption requires something different: understanding the system around the innovation.

The science may be strong, the technology may work, the investment may be there – but adoption requires something different: understanding the system around the innovation.

Who needs to believe in it?
Who makes the decision?
What evidence will persuade them?
What policy needs to change?
How should the company be positioned?
What story will make people care?
How does all of that translate into commercial growth?

How we work

We work with a small number of clients where we believe we can make a material difference. We can work as senior advisers, provide hands-on delivery, or build a specialist team around the challenge. Our engagements typically take four forms:

Board & strategic advisory

Independent counsel at board level, bringing outside perspective to strategy, reputation and growth at critical moments.

Fractional leadership

Senior strategic counsel and hands-on leadership without the cost or commitment of building a full senior function.

Adoption, market entry & growth

Focused support to sharpen the proposition, navigate the NHS, build market access and accelerate adoption and growth.

Strategic projects & campaigns

Intensive programmes around policy and influence, brand and positioning, reputation, funding, launches or critical corporate moments.

Who we work with

Growth-stage health & life sciences companies

Health tech, life sciences, genomics, digital health, AI and other science-led businesses moving from innovation towards adoption and scale.

Founders and leadership teams

Teams that need experienced senior counsel and specialist capability at a critical stage — without building a large permanent corporate affairs, marketing or strategy function.

Investors

VC and private equity investors seeking strategic support for portfolio companies – from proposition and market entry to NHS adoption, positioning and growth.

About us

We combine system influence with market influence — creating the conditions for adoption while building the brand, reputation and demand required for growth.

Sian Jarvis CB

Sian Jarvis CB

Founder

About Sian

SH

Stephen Hankinson

Brand & Marketing

About Stephen

Partnership

How we partner with the Bluedoor Group to unlock the US market

How we partner with the Bluedoor Group to unlock the US market

How we partner with the Bluedoor Group to unlock the US market

Jarvis Associates helps health and life sciences companies navigate the journey from innovation to adoption in the UK. Through our partnership with Bluedoor, we extend that capability into the US — combining deep health-system expertise, commercialisation, customer insight and market intelligence to support growth on both sides of the Atlantic.

Jarvis Associates helps health and life sciences companies navigate the journey from innovation to adoption in the UK. Through our partnership with Bluedoor, we extend that capability into the US — combining deep health-system expertise, commercialisation, customer insight and market intelligence to support growth on both sides of the Atlantic.

Jarvis Associates helps health and life sciences companies navigate the journey from innovation to adoption in the UK. Through our partnership with Bluedoor, we extend that capability into the US — combining deep health-system expertise, commercialisation, customer insight and market intelligence to support growth on both sides of the Atlantic.

Commercialisation expertise

Turning strategy and positioning into customer validation, commercial traction and growth.

Market & competitive intelligence

Market analysis and opportunity assessment to find where the strongest growth lies.

Healthcare buyer experience

Firsthand understanding of how health systems, payers and employers evaluate and adopt new solutions.

Customer & patient insight

Research, buyer-journey and behavioural science that validates propositions with the people who matter.

Digital health & AI expertise

Deep experience across digital health, diagnostics, AI and patient engagement.

US market entry

A proven, stage-gated approach to validating US opportunity without over-investing too early.

US healthcare network

Access to health systems, payers, investors and commercialisation partners across the US.

Investor & portfolio support

Commercial diligence and hands-on growth support for VC/PE firms and their portfolios.

Two-way international reach

A route for Jarvis clients into the US, and for Bluedoor’s US clients into the UK and NHS.

A flexible senior team

The right strategy, research and commercial expertise around each opportunity, without fixed overhead.

Have an innovation that should be changing healthcare?

If the science works but adoption, positioning or growth isn’t moving fast enough, let’s talk.

Jarvis Associates

Strategic advisory for ambitious health and life sciences companies.

© 2026 Jarvis Associates. All rights reserved.

Have an innovation that should be changing healthcare?

If the science works but adoption, positioning or growth isn’t moving fast enough, let’s talk.

Jarvis Associates

Strategic advisory for ambitious health and life sciences companies.

© 2026 Jarvis Associates. All rights reserved.

Have an innovation that should be changing healthcare?

If the science works but adoption, positioning or growth isn’t moving fast enough, let’s talk.

Jarvis Associates

Strategic advisory for ambitious health and life sciences companies.

© 2026 Jarvis Associates. All rights reserved.